On the public citation graph
HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model
0 signed · 46 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jgm.1453openalex-snapshot
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir
inferredcites →https://doi.org/10.1002/rmv.589openalex-snapshot
Clinical features and treatment of adenovirus infections
inferredcites →https://doi.org/10.1016/b978-0-12-398342-8.00003-3openalex-snapshot
Syrian Hamster as an Animal Model to Study Oncolytic Adenoviruses and to Evaluate the Efficacy of Antiviral Compounds
inferredcites →https://doi.org/10.1016/j.antiviral.2006.04.007openalex-snapshot
Antiviral therapy for adenovirus infections
inferredcites →https://doi.org/10.1016/j.antiviral.2014.10.005openalex-snapshot
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model
inferredcites →https://doi.org/10.1016/j.bbmt.2011.09.007openalex-snapshot
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
inferredcites →https://doi.org/10.1016/j.bbmt.2014.11.136openalex-snapshot
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
inferredcites →https://doi.org/10.1016/j.bbmt.2016.12.621openalex-snapshot
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial
inferredcites →https://doi.org/10.1016/j.jcv.2016.07.021openalex-snapshot
The use of brincidofovir for the treatment of mixed dsDNA viral infection
inferredcites →https://doi.org/10.1016/j.virol.2009.08.038openalex-snapshot
Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents
inferredcites →https://doi.org/10.1016/j.virol.2010.10.041openalex-snapshot
Characterization of species C human adenovirus serotype 6 (Ad6)
inferredcites →https://doi.org/10.1038/cgt.2009.5openalex-snapshot
An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector
inferredcites →https://doi.org/10.1038/cgt.2009.6openalex-snapshot
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies
inferredcites →https://doi.org/10.1038/sj.bmt.1702555openalex-snapshot
Donor leukocyte infusions in acute lymphocytic leukemia
inferredcites →https://doi.org/10.1053/j.ajkd.2005.02.010openalex-snapshot
Antiviral Drug-Induced Nephrotoxicity
inferredcites →https://doi.org/10.1055/s-0036-1584923openalex-snapshot
Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention
inferredcites →https://doi.org/10.1073/pnas.0800200105openalex-snapshot
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
inferredcites →https://doi.org/10.1086/505498openalex-snapshot
Emerging Infections: Adenovirus Infections in Transplant Recipients
inferredcites →https://doi.org/10.1099/vir.0.003087-0openalex-snapshot
Adenoviruses: update on structure and function
inferredcites →https://doi.org/10.1111/tid.12582openalex-snapshot
Brincidofovir clearance of acyclovir‐resistant herpes simplex virus‐1 and adenovirus infection after stem cell transplantation
inferredcites →https://doi.org/10.1128/aac.03860-14openalex-snapshot
Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters
inferredcites →https://doi.org/10.1128/cmr.00052-07openalex-snapshot
Adenoviruses in Immunocompromised Hosts
inferredcites →https://doi.org/10.1128/cmr.00116-13openalex-snapshot
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
inferredcites →https://doi.org/10.1128/jvi.00284-17openalex-snapshot
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5
inferredcites →https://doi.org/10.1158/0008-5472.can-05-3497openalex-snapshot
Syrian Hamster as a Permissive Immunocompetent Animal Model for the Study of Oncolytic Adenovirus Vectors
inferredcites →https://doi.org/10.1182/blood-2010-04-259291openalex-snapshot
How I treat adenovirus in hematopoietic stem cell transplant recipients
inferredcites →https://doi.org/10.1385/1-59745-166-5:223openalex-snapshot
Preparation and Titration of CsCl-Banded Adenovirus Stocks
inferredcites →https://doi.org/10.1517/14656566.2015.1083975openalex-snapshot
New drug on the horizon for treating adenovirus
inferredcites →https://doi.org/10.1556/oh.2012.29496openalex-snapshot
Adenovirus infections in immuncompromised patients
inferredcites →https://doi.org/10.1586/14787210.2013.836964openalex-snapshot
Diagnosis and treatment of adenovirus infection in immunocompromised patients
inferredcites →https://doi.org/10.2165/00003088-200948030-00001openalex-snapshot
Sex Differences in Pharmacokinetics and Pharmacodynamics
inferredcites →https://doi.org/10.3390/v7031409openalex-snapshot
Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/1873-3468.13848openalex-snapshot
The Adenovirus Death Protein – a small membrane protein controls cell lysis and disease
inferred← citeshttps://doi.org/10.1002/jmv.29026openalex-snapshot
A novel humanized tri‐receptor transgenic mouse model of HAdV infection and pathogenesis
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105799openalex-snapshot
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters
inferred← citeshttps://doi.org/10.1080/09273948.2019.1624780openalex-snapshot
Human Adenovirus: An Unusual Causative Agent for Acute Retinal Necrosis Presented with Central Retinal Vascular Occlusion
inferred← citeshttps://doi.org/10.1093/femsre/fuz008openalex-snapshot
Drug development against human adenoviruses and its advancement by Syrian hamster models
inferred← citeshttps://doi.org/10.1101/2024.11.01.621456openalex-snapshot
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster model
inferred← citeshttps://doi.org/10.1126/sciadv.abm8563openalex-snapshot
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
inferred← citeshttps://doi.org/10.1128/aac.00489-24openalex-snapshot
NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster model
inferred← citeshttps://doi.org/10.1128/aac.01299-20openalex-snapshot
Filociclovir Is a PotentIn VitroandIn VivoInhibitor of Human Adenoviruses
inferred← citeshttps://doi.org/10.3390/biology10121253openalex-snapshot
Animal Models in Human Adenovirus Research
inferred← citeshttps://doi.org/10.3390/v10050243openalex-snapshot
Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9
inferred← citeshttps://doi.org/10.3390/v16081200openalex-snapshot
Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.